Sarah Pinder is Chair of Breast Pathology at Kings College London. She is Lead Breast Pathologist at Guy’s & St Thomas’ Hospitals (50% time NHS) with a large external referral practice. She Chairs the National Coordinating Committee for Breast Pathology (NCCBP) for the Royal College of Pathologists/UK NHS Breast Screening Programme (BSP) and is a member of several other BSP committees, such as the Advisory Committee for Breast Cancer Screening and the Research Advisory Committee. She is a member of a number of clinical trial and translational research committees, including the low risk DCIS trial (LORIS) (for which she is one of three central review pathologists) and OPTIMA, amongst others. She is a founder member of Sloane Project Steering Group and her translational research interests are focused particularly on in situ breast carcinoma. She has published over 300 articles in the peer-reviewed literature, and over 100 invited articles and chapters.